👋
Is this profile yours? Take control to keep your details current, set fees, and respond to reviews.
This page is aggregated from public sources.
Claim this profile →
Trust score 8/100
Accepting new patients
Dr
Dr Geoffrey Lindeman
Oncology
English
4,592+
Patients seen
2
Years in practice
8
Publications
1
Languages spoken
About
Dr Geoffrey Lindeman is a clinician-scientist. Their primary areas of research include immunotherapy, fundamental biology, personalised medicine, cell signalling, cell death, epigenetics, and transcriptional regulation. They study molecular regulators of normal mammary gland development and cancer. Their work focuses on understanding how mammary stem cells and their progeny contribute to the mammary epithelial cell hierarchy and breast cancer. This led to the discovery of RANK-positive progenitors as a target for breast cancer prevention in BRCA1 mutation carriers. Their laboratory uses patient-derived xenograft (PDX) and tumour organoid models to test promising anti-cancer agents.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Geoffrey Lindeman
Education & training
-
2017–2023 MD · Medicine and Surgery
-
2023–2027 Residency · Oncology
-
2027–2028 Fellowship · Subspecialty training
Career & appointments
-
2027-09–2028-08 Junior consultant
Licenses & insurance
Medical licenses
— Organización Médica Colegial de España (OMC)
Board certifications
European Board of Oncology
Malpractice insurance:
HDI Global · 5,000,000 EUR coverage
· No claims on file
Procedures performed
| Procedure | Code | Lifetime count |
|---|---|---|
| GP consultation | 99213 | 173 |
| Annual physical exam | 99395 | 3,019 |
| Vaccination administration | 90471 | 891 |
| Minor procedure (skin) | 17110 | 1,108 |
Services & pricing
| Service | Duration | Modality | Price |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 60 min | in_clinic | 810.00 EUR |
| Minor procedure (skin) | 90 min | in_clinic | 540.00 EUR |
Office, team & in practice
Videos
Research & publications
h-index: 7 · i10: 16
-
Outcomes of Oncology in adults — a multi-centre cohort
DOI: 10.9854/euroclin.2025.0 · PMID: 32585409 · cited by 61
-
European registry analysis of Oncology outcomes
DOI: 10.1549/euroclin.2024.1 · PMID: 36722506 · cited by 119
-
Outcomes of Oncology in adults — a multi-centre cohort
DOI: 10.2721/euroclin.2023.2 · PMID: 31319038 · cited by 57
-
European registry analysis of Oncology outcomes
DOI: 10.8432/euroclin.2022.3 · PMID: 30375883 · cited by 107
Invited talks
- Practical updates in Oncology European Annual Congress (Oncology) · Vienna · 2024 · invited
- Single-centre experience in Oncology National Society Meeting · · 2023 · oral abstract
Awards & memberships
Awards
- 🏆 Top-rated Oncology — · EuroClinics Patient Choice · 2025 · regional
Society memberships
- WONCA Europe — Family Doctors — Member · since 2028
- national college of family doctors — Member · since 2028
- European Union of Medical Specialists (UEMS) — Member · since 2028
Patient reviews
- Bedside Manner
- 0.05
- Knowledge
- 0.08
- Wait Time
- 3.80
- Staff Friendliness
- 0.02
- Ease Of Appointment
- 4.00
- Value For Money
- 4.10
- Would Recommend Pct
- 4
-
★ 5 verified visit
“Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.”
-
★ 5 verified visit
“Took time to listen and reviewed all my previous results. I would absolutely recommend.”
-
★ 4 verified visit
“Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.”
Articles by this doctor
- Patient education Patient guide to Oncology
- Awareness When should you see a oncology?
For international patients
- Coordinator
- Patient liaison · geoffrey.lindeman@euroclinics.example
